Form 4 filings across 9 companies. Net figures count open-market buys and sales only. EDGAR profile ↗
Lifetime net: -$906.9M
Reported holding is the most recent post-transaction share count on a Table I row.
How quickly this filer reports. Section 16 allows two business days from the transaction.
All 10 filings we hold were filed within the two-business-day deadline.
Counted in business days from the transaction date, or the deemed execution date where the filing reports one, excluding weekends and federal holidays. How this is measured · All late filings
The 23 most recent Form 4 transactions.
| $242.6M |
| -$242.6M |
| 5.5M |
| Mar 31 |
| ZBIO | Zenas BioPharma, Inc. | $3M | $0 | +$3M | 2.4M | Mar 31 |
| DMRA | Damora Therapeutics, Inc. | $0 | $0 | $0 | — | Mar 23 |
| Aug 7 | APGE | Apogee Therapeutics, Inc. | MEXER | 10,370 | $43.85 | $454.7K | +3.1% | Open the original filing on SEC.gov |
| Aug 7 | APGE | Apogee Therapeutics, Inc. | MEXER | 31,838 | $17.00 | $541.2K | +10.7% | Open the original filing on SEC.gov |
| Jul 16 | CBIO | Crescent Biopharma, INC. | PDBUY◆ | 525,897 | $14.50 | $7.6M | — | Open the original filing on SEC.gov |
| Jul 16 | CBIO | Crescent Biopharma, INC. | PBUY | 853,450 | $14.50 | $12.4M | +31.1% | Open the original filing on SEC.gov |
| Jul 1 | ORKA | Oruka Therapeutics, Inc. | CCONV◆ | 42,641 | — | — | — | Open the original filing on SEC.gov |
| Jul 1 | ORKA | Oruka Therapeutics, Inc. | SSELL | 3.6M | $84.43 | $300M | -75.8% | Open the original filing on SEC.gov |
| Jul 1 | ORKA | Oruka Therapeutics, Inc. | CCONV | 3.6M | — | — | +313.9% | Open the original filing on SEC.gov |
| Jun 23 | SYRE | Spyre Therapeutics, Inc. | CCONV◆ | 16,667 | — | — | — | Open the original filing on SEC.gov |
| Jun 23 | SYRE | Spyre Therapeutics, Inc. | SSELL | 4.7M | $85.31 | $399.7M | -100.0% | Open the original filing on SEC.gov |
| Jun 23 | SYRE | Spyre Therapeutics, Inc. | CCONV | 666,680 | — | — | +16.6% | Open the original filing on SEC.gov |
| Jun 9 | JBIO | Jade Biosciences, Inc. | AGRANT◆ | 34,843 | — | — | — | Open the original filing on SEC.gov |
| Jun 9 | APGE | Apogee Therapeutics, Inc. | AGRANT◆ | 7,657 | — | — | — | Open the original filing on SEC.gov |
| Jun 2 | ORKA | Oruka Therapeutics, Inc. | AGRANT◆ | 9,136 | — | — | — | Open the original filing on SEC.gov |
| Jun 2 | CBIO | Crescent Biopharma, INC. | AGRANT◆ | 11,050 | — | — | — | Open the original filing on SEC.gov |
| May 27 | SYRE | Spyre Therapeutics, Inc. | AGRANT◆ | 8,026 | — | — | — | Open the original filing on SEC.gov |
| May 11 | VRDN | Viridian Therapeutics,… | PBUY | 1.2M | $17.00 | $20M | +30.0% | Open the original filing on SEC.gov |
| Mar 31 | COGT | Cogent Biosciences, Inc. | CCONV◆ | 28,000 | — | — | — | Open the original filing on SEC.gov |
| Mar 31 | COGT | Cogent Biosciences, Inc. | SSELL | 7M | $34.66 | $242.6M | -56.0% | Open the original filing on SEC.gov |
| Mar 31 | COGT | Cogent Biosciences, Inc. | CCONV | 7M | — | — | +127.2% | Open the original filing on SEC.gov |
| Mar 31 | ZBIO | Zenas BioPharma, Inc. | PBUY | 150,000 | $20.00 | $3M | +6.8% | Open the original filing on SEC.gov |
| Mar 23 | DMRA | Damora Therapeutics, Inc. | AGRANT◆ | 37,313 | — | — | — | Open the original filing on SEC.gov |